rs11845676
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_014844.5(TECPR2):c.1156G>A(p.Ala386Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0118 in 1,603,288 control chromosomes in the GnomAD database, including 613 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_014844.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TECPR2 | NM_014844.5 | c.1156G>A | p.Ala386Thr | missense_variant | 8/20 | ENST00000359520.12 | NP_055659.2 | |
TECPR2 | NM_001172631.3 | c.1156G>A | p.Ala386Thr | missense_variant | 8/17 | NP_001166102.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TECPR2 | ENST00000359520.12 | c.1156G>A | p.Ala386Thr | missense_variant | 8/20 | 1 | NM_014844.5 | ENSP00000352510.7 | ||
TECPR2 | ENST00000558678.1 | c.1156G>A | p.Ala386Thr | missense_variant | 8/17 | 1 | ENSP00000453671.1 |
Frequencies
GnomAD3 genomes AF: 0.0382 AC: 5817AN: 152204Hom.: 306 Cov.: 32
GnomAD3 exomes AF: 0.0138 AC: 3437AN: 248572Hom.: 135 AF XY: 0.0113 AC XY: 1521AN XY: 134572
GnomAD4 exome AF: 0.00904 AC: 13115AN: 1450966Hom.: 307 Cov.: 31 AF XY: 0.00838 AC XY: 6027AN XY: 719078
GnomAD4 genome AF: 0.0382 AC: 5822AN: 152322Hom.: 306 Cov.: 32 AF XY: 0.0370 AC XY: 2753AN XY: 74484
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 49 Benign:2
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 20, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Hereditary spastic paraplegia Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Dec 10, 2021 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at